TruScreen Group Limited
Research TruScreen Group Limited (TRU.AX) on Bullrun: market cap AUD 8.91M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTRU.AX
- ExchangeAU
- CountryNew Zealand
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Market capAUD 8.91M
- Financial periodFY2026
- RevenueNZD 2.43M
- Revenue growth42.2%
- Net income-NZD 2.25M
- Free cash flow-NZD 2.47M
- Gross margin31.5%
Valuation Snapshot
latest market cap is AUD 8.91M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | NZD 2.43M | -NZD 2.25M | -NZD 2.47M | 31.5% | 0 | NZD 1.46M | NZD 200.70K | NZD 2.59M |
| FY2025 | NZD 1.71M | -NZD 2.24M | -NZD 2.29M | 30.1% | 0 | NZD 365.47K | NZD 317.37K | NZD 1.01M |
| FY2024 | NZD 2.11M | -NZD 2.05M | -NZD 2.03M | 31.8% | 0 | NZD 2.73M | n/a | NZD 3.23M |
| FY2023 | NZD 1.66M | -NZD 2.40M | -NZD 2.24M | 27.7% | -0.01 | NZD 2.16M | n/a | NZD 2.54M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | AUD 8.91M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About TruScreen Group Limited
TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Central Asia, Vietnam, Zimbabwe, Indonesia, India, and the Middle East/North Africa. It offers TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is TruScreen Group Limited's market cap?
TruScreen Group Limited's market capitalization is AUD 8.91M.
What does TruScreen Group Limited do?
TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Central Asia, Vietnam, Zimbabwe, Indonesia, India, and the Middle East/North Africa. It offers TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to TruScreen Group Limited in August 2020.